TIGIT and neoplasm: In line with previous reports, the frequency of TIGIT expression was significantly elevated on tumour-infiltrating CD4+ Tregs compared to those in the blood (59.1% ± 7.1% versus 37.8% ± 3.7%), and slightly elevated in the tumour-infiltrating non-Treg CD4 + T cell compartment (16.9% ±3.4% versus 9.1% ± 1.2%; Fig. 1a).